艾司氯胺酮联合不同剂量右美托咪定对肺癌手术患者的镇痛效果研究

doi:10.3760/cma.j.issn.1007-1245.2023.13.016

国际医药卫生导报 ›› 2023, Vol. 29 ›› Issue (13): 1845-1849.DOI: 10.3760/cma.j.issn.1007-1245.2023.13.016

艾司氯胺酮联合不同剂量右美托咪定对肺癌手术患者的镇痛效果研究

李荔丽¹ 冯趁霞¹ 冯桂真¹ 孟双楠¹ 李喜龙²

¹开封市肿瘤医院麻醉科，开封　475000；²河南省肿瘤医院麻醉科，郑州　450000

收稿日期:2023-05-05 出版日期:2023-07-01 发布日期:2023-07-21
通讯作者: 李荔丽，Email：llililishi@163.com
基金资助:
河南省医学科技攻关项目（LHGJ20200184）

Analgesic effects of esketamine combined with different doses of dexmedetomidine in lung cancer surgery

Li Lili¹, Feng Chenxia¹, Feng Guizhen¹, Meng Shuangnan¹, Li Xilong²

¹Department of Anesthesiology, Kaifeng Cancer Hospital, Kaifeng 475000, China; ²Department of Anesthesiology, Henan Cancer Hospital, Zhengzhou 450000, China

Received:2023-05-05 Online:2023-07-01 Published:2023-07-21
Contact: Li Lili, Email: llililishi@163.com
Supported by:
Medical Science and Technology Research Project of Henan Province (LHGJ20200184)

摘要/Abstract

摘要：

目的　观察艾司氯胺酮联合不同剂量右美托咪定对肺癌手术患者的镇痛效果。方法　本文为随机对照试验。病例纳入时间为2020年8月至2022年1月，研究对象为开封市肿瘤医院收治的128例肺癌患者，应用抽签法将患者均分为两组。将采用艾司氯胺酮辅助麻醉诱导及0.5 µg/（kg·h）右美托咪定维持麻醉的64例患者列为常规组，其中男45例，女19例，年龄（49.12±5.33）岁；将采用艾司氯胺酮辅助麻醉诱导及0.3 µg/（kg·h）右美托咪定维持麻醉的64例患者列为低剂量组，其中男44例，女20例，年龄（48.77±5.25）岁。比较两组患者围手术期体征指标变化情况、术后苏醒质量、认知功能及麻醉相关不良反应。统计学方法采用独立样本t检验、配对t检验、χ²检验。结果　麻醉10 min后，低剂量组的心率（HR）［（73.33±10.45）次/min比（72.16±10.23）次/min］、平均动脉压（MAP）［（102.44±20.27）mmHg（1 mmHg=0.133 kPa）比（102.33±20.46）mmHg］与常规组比较差异均无统计学意义（均P>0.05）；术毕，低剂量组的HR［（76.22±5.35）次/min比（74.22±10.35）次/min］、MAP［（104.77±8.24）mmHg比（103.25±8.31）mmHg］与常规组比较差异均无统计学意义（均P>0.05）。术后，低剂量组视觉模拟评分法（VAS）评分与常规组［（3.36±1.25）分比（2.77±1.04）分］比较差异无统计学意义（P>0.05）；低剂量组的睁眼时间［（10.27±2.11）min比（12.77±2.36）min］、拔管时间［（11.75±2.58）min比（13.49±2.49）min］均短于常规组，苏醒后Ramsay镇静评分低于常规组［（4.42±1.45）分比（5.25±1.33）分］，差异均有统计学意义（均P<0.05）；低剂量组的简易智力检查量表（MMSE）评分［（25.64±5.28）比（22.33±5.46）分］、蒙特利尔认知评估量表（MoCA）评分［（25.79±5.18）分比（22.69±5.33）分］均高于常规组（均P<0.05）。低剂量组的麻醉相关不良反应发生率低于常规组［4.69%（3/64）比15.63%（10/64）］，差异有统计学意义（χ²=6.556，P=0.010）。结论　艾司氯胺酮辅助麻醉诱导及低剂量右美托咪定维持麻醉可产生理想的镇痛效果，并维持肺癌患者围手术期体征稳定，对促进患者术后苏醒、避免认知功能损伤有积极意义，安全性高。

关键词:

肺癌, 艾司氯胺酮, 右美托咪定, 镇痛效果, 认知功能

Abstract:

Objective　To observe the analgesic effects of esketamine combined with different doses of dexmedetomidine in lung cancer surgery. Methods　This was a randomized controlled trial. From August 2020 to January 2022, 128 patients with lung cancer admitted to Kaifeng Cancer Hospital were divided into two groups by the lottery method. Sixty-four patients receiving esketamine assisted anesthesia induction and maintenance of anesthesia with 0.5 µg/(kg·h) dexmedetomidine were classified as the routine group, including 45 males and 19 females, aged (49.12±5.33) years. Sixty-four patients receiving esketamine assisted anesthesia induction and maintenance of anesthesia with 0.3 µg/(kg·h) dexmedetomidine were classified as the low-dose group, including 44 males and 20 females, aged (48.77±5.25) years. The changes of perioperative signs, postoperative recovery quality, cognitive function, and anesthesia-related adverse reactions were compared between the two groups. The statistical methods used were independent sample t test, paired t test, and χ² test. Results　Ten min after anesthesia (T1), the heart rates (HR) and mean arterial pressures (MAP) of the low-dose group and the routine group [(73.33±10.45) beats/min vs. (72.16±10.23) beats/min, (102.44±20.27) mmHg (1 mmHg=0.133) vs. (102.33±20.46) mmHg] showed no statistically significant differences (both P>0.05). At the end of surgery (T2), the HR and MAP of the low-dose group and the routine group [(76.22±5.35) beats/min vs. (74.22±10.35) beats/min, (104.77±8.24) mmHg vs. (103.25±8.31) mmHg] showed no statistically significant differences (both P>0.05). After surgery, there was no statistically significant difference in the Visual Analogue Scale (VAS) score between the low-dose group and the routine group [(3.36±1.25) points vs. (2.77±1.04) points] (P>0.05); the eye opening time [(10.27±2.11) min vs. (12.77±2.36) min] and extubation time [(11.75±2.58) min vs. (13.49±2.49) min] in the low-dose group were shorter than those in the routine group, and the Ramsay sedation score after recovery was lower than that in the routine group [(4.42±1.45) points vs. (5.25±1.33) points], with statistically significant differences (all P<0.05). After surgery, the scores of Mini-Mental State Examination (MMSE) [(25.64±5.28) points vs. (22.33±5.46) points] and Montreal Cognitive Assessment Scale (MoCA) [(25.79±5.18) points vs. (22.69±5.33) points] in the low-dose group were higher than those in the routine group (both P<0.05). The incidence of anesthesia-related adverse reactions in the low-dose group was lower than that in the routine group [4.69% (3/64) vs. 15.63% (10/64)], with a statistically significant difference (χ²=6.556, P=0.010). Conclusion　Esketamine assisted anesthesia induction and maintenance of anesthesia with low-dose dexmedetomidine can produce ideal analgesic effect, and maintain the stability of perioperative signs in lung cancer patients, which has positive significance in promoting their postoperative recovery and avoiding the cognitive function injury, with high safety.

Key words:

Lung cancer, Esketamine, Dexmedetomidine, Analgesic effect, Cognitive function

李荔丽冯趁霞冯桂真孟双楠李喜龙.

艾司氯胺酮联合不同剂量右美托咪定对肺癌手术患者的镇痛效果研究 [J]. 国际医药卫生导报, 2023, 29(13): 1845-1849.

Li Lili, Feng Chenxia, Feng Guizhen, Meng Shuangnan, Li Xilong.

Analgesic effects of esketamine combined with different doses of dexmedetomidine in lung cancer surgery [J]. International Medicine and Health Guidance News, 2023, 29(13): 1845-1849.

参考文献

[1] 唐季春,简金金,王海浪,等. 胸椎旁神经阻滞联合舒芬太尼多模式镇痛对胸腔镜肺癌根治术患者术后镇痛及安全性分析[J]. 中外医学研究,2023,21(1):27-32. DOI:10.14033/j.cnki.cfmr.2023.01.007.
[2] 刘学佳,丁保峰,杨春晓,等. 全凭静脉麻醉和静吸复合麻醉对老年肺癌根治术患者麻醉质量及术后认知功能的影响[J]. 川北医学院学报,2022,37(6):780-783. DOI:10.3969/j.issn.1005-3697.2022.06.023.
[3] 苏洋,周峰,丁金磊. 艾司氯胺酮复合舒芬太尼对胸腔镜肺癌根治术后情绪及镇痛的影响[J]. 中国临床药理学与治疗学,2023,28(1):59-65. DOI:10.12092/j.issn.1009-2501. 2023.01.008.
[4] 杨春,刘寒玉,刘存明. 艾司氯胺酮的临床应用进展[J]. 临床麻醉学杂志,2023,39(4):414-417. DOI:10.12089/jca. 2023.04.015.
[5] 张德凤,谭永星. 右美托咪定作为佐剂在围术期周围神经阻滞中的应用进展[J]. 国际医药卫生导报,2021,27(13):2035-2039. DOI:10.3760/cma.j.issn.1007-1245.2021. 13.034.
[6] 梁磊,袁晚秋,曾进福,等. 右美托咪定对肺癌根治术单肺通气患者炎症因子及应激反应的影响[J]. 中国当代医药,2022,29(36):124-127. DOI:10.3969/j.issn.1674-4721. 2022.36.033.
[7] 赫捷,李霓,陈万青,等. 中国肺癌筛查与早诊早治指南(2021,北京)[J]. 中华肿瘤杂志,2021,43(3):243-268. DOI:10.3760/cma.j.cn112152-20210119-00060.
[8] 陈乙婕,费毅,陈献珊,等. 肺癌根治术后并发症危险因素分析及其生活质量变化研究[J]. 现代生物医学进展,2021,21(17):3315-3319,3345. DOI:10.13241/j.cnki.pmb.2021. 17.025.
[9] Shivali S, Thiagarajan P. A practical guide to the American Society of Anesthesiologists-physical status classification (ASA-PS)[J]. Indian J Anaesth, 2022, 66(4): 299-300. DOI: 10.4103/ija.ija_526_21.
[10] 刘芳芳,徐海军. 右美托咪定复合全身麻醉在老年高血压肺癌患者胸腔镜根治术中的效果分析[J]. 中国现代医学杂志,2021,31(6):64-70. DOI:10.3969/j.issn.1005-8982.2021. 06.012.
[11] 翟春丽. 腰硬联合麻醉患者应用右美托咪定的镇静效果及对Ramsay评分的影响分析[J]. 中国现代药物应用,2021,15(19):153-156. DOI:10.14164/j.cnki.cn11-5581/r.2021. 19.058.
[12] Ou C, Li C, An X, et al. Assessment of cognitive impairment in patients with cerebral infarction by MMSE and MoCA scales[J]. J Coll Physicians Surg Pak, 2020, 30(3): 342-343. DOI: 10.29271/jcpsp.2020.03.342.
[13] Chen C, Zhu Y, Chen Y, et al. Effects of cerebral artery thrombectomy on efficacy, safety, cognitive function and peripheral blood Aβ, IL-6 and TNF-α levels in patients with acute cerebral infarction[J]. Am J Transl Res, 2021, 13(12): 14005-14014.
[14] 秦娜,马红霞,靳光付,等. 肺癌流行病学研究年度进展2022[J]. 中华医学杂志,2023,103(14):1068-1073. DOI:10.3760/cma.j.cn112137-20221213-02640.
[15] 张艳梅,王迪,曹汉忠,等. 右美托咪定结合羟考酮复合麻醉对肺癌根治术患者术后痛敏反应及免疫应答影响[J]. 临床军医杂志,2022,50(2):211-213. DOI:10.16680/j.1671-3826.2022.02.29.
[16] 王金凤,徐海军,戚钰,等. 艾司氯胺酮复合舒芬太尼自控静脉镇痛对胸腔镜肺癌根治患者术后疲劳及免疫功能的影响[J]. 中国临床医学,2022,29(6):982-986. DOI:10.12025/j.issn.1008-6358.2022.20221875.
[17] Bahar E, Yoon H. Lidocaine: a local anesthetic, its adverse effects and management[J]. Medicina (Kaunas), 2021, 57(8): 782. DOI: 10.3390/medicina57080782.
[18] 陈永旺,唐霓,肖万莉,等. 小剂量艾司氯胺酮对胸腔镜肺癌根治术患者术后恢复质量的影响[J]. 中国医药导报,2022,19(19):111-114.
[19] 关柏锐,黄丹辉. 不同剂量右美托咪定持续输注复合全身麻醉对老年肺癌根治术患者的效果分析[J]. 临床医学工程,2022,29(6):815-816. DOI:10.3969/j.issn.1674-4659. 2022.06.0815.
[20] 曾举,张志军. 不同剂量右美托咪定对老年非小细胞肺癌患者术后认知功能及E-selectin、β-EP的影响[J]. 齐齐哈尔医学院学报,2021,42(14):1207-1211. DOI:10.3969/j.issn.1002-1256.2021.14.003.

艾司氯胺酮联合不同剂量右美托咪定对肺癌手术患者的镇痛效果研究

Analgesic effects of esketamine combined with different doses of dexmedetomidine in lung cancer surgery

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 6

编辑推荐

Metrics

[1]	侯静静郝蕊杨秋敏. 头孢他啶注射液辅助肺癌化疗对肺部感染的防治效果分析 [J]. 国际医药卫生导报, 2023, 29(9): 1249-1253.
[2]	刘运慧杨秋敏林春丽. 多拉司琼对肺癌根治术后恶心呕吐的效果 [J]. 国际医药卫生导报, 2023, 29(7): 940-943.
[3]	范皖程梁强刘翠中陈金瓶伍媛. 肺癌合并耶氏肺孢子菌肺炎患者1例的全科管理 [J]. 国际医药卫生导报, 2023, 29(7): 1007-1010.
[4]	邢淑静滑兰兰. 罕见RET融合及MET扩增双突变的肺癌脑转移1例 [J]. 国际医药卫生导报, 2023, 29(4): 574-576.
[5]	刘湘杰林华赋程芳李日长张小丹李伟健. 艾司氯胺酮对肥胖患者全身麻醉手术瑞芬太尼用量和术后疼痛的影响 [J]. 国际医药卫生导报, 2023, 29(2): 265-.
[6]	温海茹张乐张琴. 右美托咪定复合小剂量舒芬太尼在老年无痛胃肠镜中的效果及对认知功能影响 [J]. 国际医药卫生导报, 2023, 29(10): 1396-1399.